<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-112374</identifier>
<setSpec>0213-005X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">No disponible</dc:title>
<dc:creator>Solà, Ricard</dc:creator>
<dc:creator>Barrantes-González, Melisa</dc:creator>
<dc:creator>González-Colominas, Elena</dc:creator>
<dc:creator>Salas, Esther</dc:creator>
<dc:language>es</dc:language>
<dc:source>Enferm Infecc Microbiol Clin;31(5): 350-351, mayo 2013. tab</dc:source>
<dc:identifier>ibc-112374</dc:identifier>
<dc:title xml:lang="es">Prevalencia de las interacciones potenciales entre el tratamiento antirretroviral y boceprevir o telaprevir en pacientes coinfectados por el virus de la inmunodeficiencia humana-virus de la hepatitis C</dc:title>
<dc:subject>^d24718^s22057</dc:subject>
<dc:subject>^d38332^s22020</dc:subject>
<dc:subject>^d33344^s22057</dc:subject>
<dc:subject>^d29638</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d1002^s22020</dc:subject>
<dc:subject>^d4409</dc:subject>
<dc:type>article</dc:type>
<dc:date>201305</dc:date>
</metadata>
</record>
</ibecs-document>
